These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

144 related items for PubMed ID: 576780

  • 1. [Antitumor effect of Corynebacterium parvum].
    Mazurek C, Chalvet H, Biozzi G, Stiffel C.
    Ann Immunol (Paris); 1977; 128(1-2):161-3. PubMed ID: 576780
    [Abstract] [Full Text] [Related]

  • 2. [Passive transfer of "Corynebacterium parvum" anti-tumour protection by stimulated peritoneal cells ].
    Mazurek C, Stiffel C, Chalvet H, Biozzi G.
    Ann Immunol (Paris); 1981; 132D(1):43-54. PubMed ID: 6896973
    [Abstract] [Full Text] [Related]

  • 3. [Effect of silica on the anti-tumour activity of "Corynebacterium parvum" (author's transl)].
    Mazurek C, Stiffel C, Chalvet H, Biozzi G.
    Ann Immunol (Paris); 1979; 130(6):815-26. PubMed ID: 232975
    [Abstract] [Full Text] [Related]

  • 4. [Effect of the age of the mouse on the action of Corynebacterium parvum in inhibiting the growth of 2 syngenetic tumors].
    Mazureka C, Stiffel C, Chalvet H, Biozzi G.
    C R Seances Acad Sci III; 1981 Oct 05; 293(4):225-8. PubMed ID: 6794870
    [Abstract] [Full Text] [Related]

  • 5. [Antitumoral activity of various doses of corynebacterium parvum as a function of the age of mice].
    Stiffel C, Chalvet H, Mazurek C.
    Ann Inst Pasteur Immunol (1985); 1985 Oct 05; 136D(1):19-27. PubMed ID: 3840664
    [Abstract] [Full Text] [Related]

  • 6. Study of the mechanism of Corynebacterium parvum anti-tumour activity. I. Protective effect on the growth of two syngeneic tumours.
    Mazurek C, Chalvet H, Stiffel CL, Biozzi G.
    Int J Cancer; 1976 Apr 15; 17(4):511-7. PubMed ID: 946965
    [Abstract] [Full Text] [Related]

  • 7. Active experimental inhibition of cancer by corynebacterium parvum.
    Wrba H, Dutter A.
    Osterr Z Onkol; 1977 Oct 20; 4(2-3):60-1. PubMed ID: 579449
    [Abstract] [Full Text] [Related]

  • 8. The effect of a single and repeated administration of Corynebacterium parvum on bone marrow macrophage colony production in syngeneic tumor-bearing mice.
    Wolmark N, Fisher B.
    Cancer Res; 1974 Nov 20; 34(11):2869-72. PubMed ID: 4419513
    [No Abstract] [Full Text] [Related]

  • 9. Effect of vaccine prepared from Corynebacterium parvum on the growth of Gardner lymphosarcoma in C3H strain mice.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984 Nov 20; 32(4):405-12. PubMed ID: 6549499
    [Abstract] [Full Text] [Related]

  • 10. Treatment of C3H mice bearing solid Gardner lymphosarcoma with vaccine prepared from Corynebacterium parvum combined with methotrexate and Alexan.
    Motycka K, Chudomel V, Bednár M, Bostík J.
    Arch Immunol Ther Exp (Warsz); 1984 Nov 20; 32(4):413-9. PubMed ID: 6549500
    [Abstract] [Full Text] [Related]

  • 11. Effect of Corynebacterium parvum on the response to irradiation of a C3H fibrosarcoma.
    Suit HD, Sedlacek R, Wagner M, Orsi L, Silobrcic V, Rothman KJ.
    Cancer Res; 1976 Apr 20; 36(4):1305-14. PubMed ID: 1260756
    [Abstract] [Full Text] [Related]

  • 12. Effect of Corynebacterium parvum on cytotoxicity of regional and nonregional lymph node cells from animals with tumors present or removed.
    Fisher B, Wolmark N, Coyle J.
    J Natl Cancer Inst; 1974 Dec 20; 53(6):1793-801. PubMed ID: 4471644
    [No Abstract] [Full Text] [Related]

  • 13. Responsiveness of senescent mice to the antitumor properties of Corynebacterium parvum.
    Yuhas JM, Ullrich RL.
    Cancer Res; 1976 Jan 20; 36(1):161-6. PubMed ID: 1247995
    [Abstract] [Full Text] [Related]

  • 14. Equipotent generation of protective antitumor immunity by various methods of dendritic cell loading with whole cell tumor antigens.
    Lambert LA, Gibson GR, Maloney M, Barth RJ.
    J Immunother; 2001 Jan 20; 24(3):232-6. PubMed ID: 11394500
    [Abstract] [Full Text] [Related]

  • 15. Correlation of antitumor chemoimmunotherapy with serum inhibition of tumor cell destruction.
    Fisher B, Hanlon J, Gebhardt M, Linta J, Saffer E.
    Cancer Res; 1978 Jan 20; 38(1):38-41. PubMed ID: 618581
    [Abstract] [Full Text] [Related]

  • 16. Further observations on the inhibition of tumor growth by Corynebacterium parvum with cyclophosphamide. X. Effect of treatment on tumor cell kinetics in mice.
    Fisher B, Gunduz N.
    J Natl Cancer Inst; 1979 Jun 20; 62(6):1545-51. PubMed ID: 286125
    [No Abstract] [Full Text] [Related]

  • 17. Antitumor immunity induced by hybrid murine tumor cells: requirements for optimal immunization.
    McCune CS, O'Donnell RW, Horan PK, Budd HS, Spennacchio JL, Chuang C, Henshaw EC.
    J Natl Cancer Inst; 1982 Sep 20; 69(3):647-52. PubMed ID: 6955557
    [Abstract] [Full Text] [Related]

  • 18. Corynebacterium parvum and cyclophosphamide as combination treatment for a murine mammary adenocarcinoma.
    Purnell DM, Bartlett GL, Kreider JW, Biro TG.
    Cancer Res; 1977 Apr 20; 37(4):1137-40. PubMed ID: 844041
    [Abstract] [Full Text] [Related]

  • 19. Mechanism of Corynebacterium Parvum anti-tumour activity. II. Protective effect in T-cell-deprived mice.
    Mazurek C, Chalvet H, Stiffel C, Biozzi G.
    Int J Cancer; 1977 Oct 15; 20(4):532-4. PubMed ID: 334678
    [Abstract] [Full Text] [Related]

  • 20. [Antitumor effect of Corynebacterium parvum on C3H mouse bearing MH-134 tumor].
    Nakamura K, Miwa H, Hashimoto O, Inoue T, Orita K.
    Gan To Kagaku Ryoho; 1982 Jul 15; 9(6):1046-51. PubMed ID: 7184438
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.